Frank Rimerman Advisors’s AbbVie ABBV Stock Holding History

Frank Rimerman Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.69M	Buy	34,526 +16	+0%	+$3.44K	0.49%	31
2026 Q1	$7.51M	Buy	34,510 +1,340	+4%	+$297K	0.49%	31
2025 Q4	$7.58M	Buy	33,170 +148	+0.4%	+$33.7K	0.48%	27
2025 Q3	$7.65M	Buy	33,022 +1,115	+3%	+$227K	0.49%	25
2025 Q2	$5.92M	Buy	31,907 +4,291	+16%	+$797K	0.4%	41
2025 Q1	$5.79M	Buy	27,616 +475	+2%	+$92.3K	0.46%	34
2024 Q4	$4.82M	Buy	27,141 +404	+2%	+$74.3K	0.35%	39
2024 Q3	$5.28M	Buy	26,737 +682	+3%	+$127K	0.37%	40
2024 Q2	$4.47M	Buy	26,055 +26,019	+72,275%	+$4.31M	0.32%	43
2024 Q1	$6.56K	Hold	36	–	–	﹤0.01%	196
2023 Q4	$5.58K	Buy	+36	New	+$5.25K	﹤0.01%	194
2021 Q2	–	Sell	-1,945	Closed	-$210K	–	83
2021 Q1	$210K	Buy	+1,945	New	+$208K	0.09%	81

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Frank Rimerman Advisors's ABBV Position: Q2 2026 in Review

Frank Rimerman Advisors increased its AbbVie (ABBV) stake by 0.05% in Q2 2026, buying an estimated $3.44K and bringing the position to 34,526 shares worth $8.69M. The position accounts for 0.49% of the portfolio, ranked #31.

Frank Rimerman Advisors first reported a position in ABBV in Q1 2021 and has held it in 12 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Frank Rimerman Advisors held 34,526 shares of AbbVie worth $8.69M as of Q2 2026.
Frank Rimerman Advisors bought 16 AbbVie shares in Q2 2026, an estimated $3.44K.
AbbVie made up 0.49% of Frank Rimerman Advisors's portfolio in Q2 2026, its #31 holding.
Frank Rimerman Advisors first reported a position in AbbVie in Q1 2021 and has held it in 12 quarters since.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Frank Rimerman Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.